Rare diseases
Investigational molecules
Locations
Back to Romania18 clinical trials in Balotesti, Romania. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in RomaniaStudii.Clinice.ro(opens in a new tab)Study on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction
RomaniaStudy on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation
RomaniaPumitamig Versus Pembrolizumab in Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%
RomaniaA study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease
RomaniaTesting MK-2870 with pembrolizumab compared to pembrolizumab alone after surgery in patients with non-small cell lung cancer who did not respond fully to treatment
RomaniaEvaluating the Effect of Vicadrostat and Empagliflozin Combination Compared to Empagliflozin Alone in Patients with Heart Failure and Reduced Left Ventricular Function
RomaniaStudy on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure
RomaniaStudy on the Effects of Oseltamivir and Drug Combination for Patients with Pneumonia
RomaniaStudy Comparing MK-5684 with Abiraterone Acetate or Enzalutamide for Patients with Advanced Prostate Cancer After Hormonal Therapy
RomaniaA study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.
RomaniaSafety and efficacy of GS-3242 drug combination compared with standard drug combination in treatment‑naive adults with HIV‑1
RomaniaA study to evaluate the effectiveness and safety of vamifeport in adults with hereditary hemochromatosis
RomaniaThe busiest research cities in the country
What the registry says about research in the country
Innovative trials exploring treatments for hypertrophic cardiomyopathy and various heart conditions, evaluating new therapeutic combinations for improved patient outcomes.
Studies focus on symptom improvement and reducing cardiovascular events in patients with various heart conditions.
Critical research addressing COVID-19 and HIV treatments, including studies of novel antiviral medications and weekly dosing regimens.
Investigations aim to improve treatment efficacy and patient convenience in managing infectious diseases.
Advanced research in metastatic prostate cancer treatment, comparing new therapeutic approaches with established treatments.
Focus on developing effective treatments for advanced-stage cancers and improving patient survival rates.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
